๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma

โœ Scribed by E. Shelley Hwang; Sarah J. Nyante; Yunn Yi Chen; Dan Moore; Sandy DeVries; James E. Korkola; Laura J. Esserman; Frederic M. Waldman


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
323 KB
Volume
100
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

BACKGROUND

Lobular carcinoma in situ (LCIS) of the breast is considered a marker for an increased risk of carcinoma in both breasts. However, the frequent association of LCIS with invasive lobular carcinoma (ILC) suggests a precursorโ€product relation. The possible genomic relation between synchronous LCIS and ILC was analyzed using the technique of arrayโ€based comparative genomic hybridization (CGH).

METHODS

Twentyโ€four samples from the University of Californiaโ€“San Francisco pathology archives that contained synchronous LCIS and ILC were identified. Array CGH was performed using random primerโ€“amplified microdissected DNA. Samples were hybridized onto bacterial artificial chromosome arrays composed of approximately 2400 clones. Patterns of alterations within synchronous LCIS and ILC were compared.

RESULTS

A substantial proportion of the genome was altered in samples of both LCIS and ILC. The most frequent alterations were gain of 1q and loss of 16q, both of which usually occurred as wholeโ€arm changes. Smaller regions of gain and loss were seen on other chromosome arms. Fourteen samples of LCIS were related more to their paired samples of ILC than to any other ILC, as demonstrated by a weighted similarity score.

CONCLUSIONS

LCIS and ILC are neoplastic lesions that demonstrate a range of genomic alterations. In the current study, the genetic relation between synchronous LCIS and ILC suggested clonality in a majority of the paired specimens. These data were consistent with a progression pathway from LCIS to ILC. The authors conclude that LCIS, which is known to be a marker for an environment that is permissive of neoplasia, may itself represent a precursor to invasive carcinoma. Cancer 2004. ยฉ 2004 American Cancer Society.


๐Ÿ“œ SIMILAR VOLUMES


Lobular carcinoma in situ
โœ Robert W. Powers; Paul H. O'Brien; Albert Kreutner JR. ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 295 KB
Lobular carcinoma in situ with microinva
โœ Nemoto, Takuma; Castillo, Nieva; Tsukada, Yoshi; Koul, Ashok; Eckhert, Kenneth H ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 255 KB ๐Ÿ‘ 2 views

Six patients with lobular carcinoma in situ with microinvasion were described in this report. Lobular carcinoma in situ is not known to progress to microinvasive disease. Although this feature is rare, the current understanding that lobular carcinoma in situ is a marker needs to be revised.

Lobular carcinoma in situ of the breast
โœ R. A. A. Macaulay; Dr M. J. Mitchinson ๐Ÿ“‚ Article ๐Ÿ“… 1973 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 392 KB ๐Ÿ‘ 2 views
Lobular carcinoma in situ of the breast
โœ Robert A. Goldschmidt; Thomas A. Victor ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 752 KB

Lobular carcinoma in situ (LCIS) of the breast is commonly identified as an incidental finding in breast biopsies performed because of either a mammographic abnormality or a palpable mass. Although long recognized as an entity, the significance and optimal treatment of LCIS remains controversial. In